← Browse by Condition
Medical Condition
ovarian clear cell carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for ovarian clear cell carcinoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
1 trial
1 trial
NCT04104776 Phase 1, Phase 2
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Enrollment
275 pts
Location
United States, Franc...
Sponsor
Novartis Pharmaceuticals
NCT06279104
Recruiting
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
Enrollment
150 pts
Location
China
Sponsor
Tongji Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology